Vitiligo is believed to be an autoimmune condition where the body attacks its own healthy melanin-producing skin cells by mistake. It may be hereditary or triggered by a particular event like ...

Within the baricitinib group, patients experienced a mean Vitiligo Area Scoring Index score change of 44.8% from baseline to week 36. In contrast, the placebo group saw a 9.2% change. The Janus ...